Mangrove Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q2
Sell
-113,349
Closed -$17.3M 487
2021
Q1
$17.3M Buy
+113,349
New +$17.3M 1.75% 3